At a glance
- Originator Pfizer
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Transplant rejection
Most Recent Events
- 14 Jul 1998 No-Development-Reported for Transplant rejection in USA (Unknown route)
- 03 Oct 1995 Preclinical development for Transplant rejection in USA (Unknown route)